SEC Filing Summary: Landec Corporation (8-K)
Business Context and Reporting Period
This Form 8-K Current Report was filed by Landec Corporation on April 13, 2005. The filing reports a specific event occurring on the same date involving the company's food subsidiary, Apio, Inc. Note: The request metadata referenced "LIFECORE BIOMEDICAL, INC.", but the source document explicitly identifies the registrant as Landec Corporation.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses solely on the announcement of a gain on the sale of land by Apio, Inc. Specific financial figures regarding the transaction amount are contained in the attached press release (Exhibit 99.1) but are not detailed within the body of this 8-K text.
Material Changes
The material change reported is the realization of a gain from the sale of land assets by the subsidiary Apio, Inc. This is classified under Item 8.01 (Other Events).
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future operations, or a discussion of risks and contingencies beyond the specific event of the land sale. The document serves strictly to incorporate the press release by reference.
Investor Verification Checklist
- Verify the exact dollar amount of the gain on the sale of land by reviewing Exhibit 99.1 (Press Release).
- Confirm the impact of this one-time gain on the company's quarterly or annual earnings per share.
- Review the terms of the land sale to understand if there are any future obligations or contingencies.
- Ensure the correct registrant (Landec Corporation) is being analyzed, as the metadata contained a discrepancy regarding the company name.